Analytical Profile: Gilead Sciences Poland Sp. z o. o.
Key data on tenders won by this company, activity trends, and recent successes.
Tenders Won (12m)
10
Total Won Value (12m)
€80.7M
Average Contract Won
€8.1M
Top Category Won
Medical equipments, pharmaceuticals and personal care products
Gilead Sciences Poland Sp. z o. o. is a company actively participating in and winning public tenders. We present an analytical overview of their wins and contract values over the past 12 months.
According to our data, this company has won 10 tenders in the last year, with a total estimated value of €80.7M. The average contract value during this period was €8.1M, providing insight into the typical size of their successful bids.
Public Data vs. Professional Intelligence
You are viewing a free, public snapshot of this company's activity. The tend.ee Professional plan unlocks real-time data, predictive analytics, and our full AI-powered competitive analysis for this and thousands of other companies.
Recent Tenders (Sample)
| Date | Title | Status | Value (EUR) |
|---|---|---|---|
| 2025-11-26 | Poland – Antivirals for systemic use – Zakup leków antyretrowirusowych. Części 1-5 | Tender Result | €14.8M |
| 2025-09-19 | Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawa produktów leczniczych typu CAR-T [Aksykabtagen cyloleucel, Breksukabtagen autoleucel] | Tender Result | €6.3M |
| 2025-09-16 | Poland – Pharmaceutical products – 227/PN/2025 - Dostawa produktu leczniczego Brexucabtagene autoleucel dla UCK | Tender Result | €3.0M |
| 2025-08-20 | Poland – Pharmaceutical products – Dostawy produktów leczniczych Brexucabtagene autoleucel, Axicabtagene ciloleucel – 2 części | Tender Result | €7.1M |
| 2025-07-28 | Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-90/25/TM | Tender Result | €20.4M |
Analyze with tend.ee AI Co-pilot
Consult your personalized AI Co-pilot on your winning strategy.
Access all 10 tenders from this category.
Get real-time alerts for new opportunities.
Analyze historical winners and competitors.
No card required. Limited-time offer with basic personalization.